Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment-free Remission”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Testing effectiveness (Phase 2)UnknownNCT04043676
What this trial is testing

Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Fundación Teófilo Hernando, Spain 40
Not applicableUnknownNCT05152537
What this trial is testing

FLOR3 Gene Polymorphism in Predicting Outcomes of Tyrosine Kinase Inhibitor（TKI）Stopping in Chronic Myeloid Leukemia

Who this might be right for
FolateCMLTreatment-free Remission
Affiliated Hospital of Nantong University 15
Not applicableUnknownNCT00449319
What this trial is testing

AML Treatment in Untreated Adult Patients

Who this might be right for
Leukemia, Myelocytic, Acute
Gruppo Italiano Malattie EMatologiche dell'Adulto
Testing effectiveness (Phase 2)Active Not RecruitingNCT03610971
What this trial is testing

Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors

Who this might be right for
Chronic Phase Chronic Myeloid LeukemiaChronic Myeloid Leukemia, Chronic Phase
H. Lee Moffitt Cancer Center and Research Institute 24
Not applicableUnknownNCT05926128
What this trial is testing

Study of Treatment Free Remission in Patients With Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
CML
Fundaleu 75
Testing effectiveness (Phase 2)Study completedNCT01784068
What this trial is testing

Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 215
Large-scale testing (Phase 3)Study completedNCT02980731
What this trial is testing

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
AbbVie 210
Not applicableUnknownNCT04422171
What this trial is testing

A 12-month Real Life Study of IBD Patients Switched From Adalimumab Originator Humira® to One of Its Biosimilar

Who this might be right for
IBD Patients, Originator Treatment, Biosimilar, Switch Back
University Hospital, Grenoble 400
Testing effectiveness (Phase 2)Study completedNCT01744665
What this trial is testing

A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation

Who this might be right for
CML
Novartis Pharmaceuticals 59
Not applicableNot Yet RecruitingNCT05440747
What this trial is testing

Treatment Free Remission (TFR) in CML Patients （CML-CP）Study

Who this might be right for
Chronic Myeloid LeukemiaTreatment-free Remission
Guangdong Provincial People's Hospital 203
Testing effectiveness (Phase 2)Active Not RecruitingNCT03817398
What this trial is testing

Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive
Children's Oncology Group 110
Large-scale testing (Phase 3)Study completedNCT01743989
What this trial is testing

Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.

Who this might be right for
Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
Novartis Pharmaceuticals 620
Not applicableLooking for participantsNCT05439889
What this trial is testing

Follow-up Study on Chronic Myeloid Leukemia Patients Achieving Treatment-free Remission

Who this might be right for
Chronic Myeloid Leukemia, BCR/ABL-Positive
National Taiwan University Hospital 100
Not applicableNot Yet RecruitingNCT07542912
What this trial is testing

Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma

Who this might be right for
Complete Remission Rate， CRRProgression Free SurvivalOverall Survival+2 more
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT01393405
What this trial is testing

Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
University of North Carolina, Chapel Hill 179
Testing effectiveness (Phase 2)Study completedNCT01301820
What this trial is testing

Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)

Who this might be right for
Acute Myeloid Leukemia
French Innovative Leukemia Organisation 120
Not applicableEnded earlyNCT02485353
What this trial is testing

Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML

Who this might be right for
Leukemia, Myeloid, Acute
Hamid Sayar 2
Testing effectiveness (Phase 2)Study completedNCT01698905
What this trial is testing

Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 163
Large-scale testing (Phase 3)Active Not RecruitingNCT05456191
What this trial is testing

Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)

Who this might be right for
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
Novartis Pharmaceuticals 568
Testing effectiveness (Phase 2)Study completedNCT02220166
What this trial is testing

Safety of Prolonged Administration of Triticum Monococcum in Celiac Disease

Who this might be right for
Celiac Disease
Università degli Studi di Brescia 8
Next Page